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Abstract
Background: Genome-wide association studies (GWAS) have linked common single nucleotide polymorphisms (SNPs) on
chromosome 9p21 near the INK4/ARF (CDKN2A/B) tumor suppressor locus with risk of atherosclerotic diseases and type 2
diabetes mellitus. To explore the mechanism of this association, we investigated whether expression of proximate
transcripts (p16
INK4a, p15
INK4b, ARF, ANRIL and MTAP) correlate with genotype of representative 9p21 SNPs.
Methodology/Principal Findings: We analyzed expression of 9p21 transcripts in purified peripheral blood T-cells (PBTL)
from 170 healthy donors. Samples were genotyped for six selected disease-related SNPs spanning the INK4/ARF locus.
Correlations among these variables were determined by univariate and multivariate analysis. Significantly reduced
expression of all INK4/ARF transcripts (p15
INK4b, p16
INK4a, ARF and ANRIL) was found in PBTL of individuals harboring a
common SNP (rs10757278) associated with increased risk of coronary artery disease, stroke and aortic aneurysm. Expression
of MTAP was not influenced by rs10757278 genotype. No association of any these transcripts was noted with five other
tested 9p21 SNPs.
Conclusions/Significance: Genotypes of rs10757278 linked to increased risk of atherosclerotic diseases are also associated
with decreased expression in PBTL of the INK4/ARF locus, which encodes three related anti-proliferative transcripts of known
importance in tumor suppression and aging.
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Introduction
Recent human genome-wide association studies (GWAS) have
shown that SNPs with high minor allele frequencies near the
INK4/ARF (CDKN2A/B) tumor suppressor locus on chromosome
9p21 correlate with risk of atherosclerotic diseases (coronary artery
disease (CAD) [1,2,3,4,5], ischemic stroke [6,7], and abdominal
aortic aneurysm[6]) and type 2 diabetes mellitus (T2DM) [8,9,10].
Evidence from our lab has suggested that expression of p16
INK4a,
one of the proteins encoded by the INK4/ARF locus, controls
pancreatic islet proliferation and mass with aging [11], and
therefore could plausibly explain the link to T2DM. The
mechanism underlying the association of these SNPs with
atherosclerotic diseases, however, is less clear.
In particular, it is not known if these genetic variants are
associated with altered expression of cis-encoded transcripts. The
most replicated SNPs associated with strongest effect sizes for
atherosclerotic disease and T2DM are .100 kb centromeric to
the INK4/ARF locus (Fig. 1), which encodes three cell cycle
inhibitors (p15
INK4b, p16
INK4a, ARF, reviewed in [12]) and a
recently discovered putative non-coding RNA designated ANRIL
[13]. There are no known cis-regulatory elements of the INK4/
ARF locus located at such a distance from the locus. It has also
been suggested that a more distant gene on 9p21, MTAP (Fig. 1),
could mediate disease associations [3,4].
In this work, we sought to determine whether there is a link
between these disease-associated SNPs and expression of 9p21
transcripts. We found that individuals harboring a common SNP
genotype associated with increased risk for atherosclerotic disease
demonstrated markedly reduced expression of INK4/ARF-encoded
transcripts inperipheral blood T-cells(PBTL), indicating a potentially
important role for cell cycle inhibitors in atherosclerotic disease.
Methods
Ethics Statement
This study was approved by the University of North Carolina
Institutional Review Board with all participants providing
informed written consent.
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The subject characteristics will be described elsewhere in details
(YL and NES, submitted). In brief, PBTLs were obtained from 170
healthy subjects and isolated to .90% purity by Magnetic
Activated Cell Sorting (MACS). MACS, RNA preparation and
transcript expression analysis were performed in PBTL as
described ([14], and YL and NES, submitted). Transcript
expression levels are presented as log2-transformed expression
(DDCT, ref. [15]). Genomic DNA was prepared from buffy coats
using Puregene Blood Core Kit (Qiagen) according to manufac-
ture’s instructions. All SNP genotyping was performed at the UNC
Mammalian Genotyping Core using TaqmanH SNP Genotyping
assays by automatic genotype calling. Allele frequencies and
linkage disequilibrium (LD) in studied subjects were comparable to
those from HapMap (Table S1). All SNP genotypes were in
Hardy-Weinberg Equilibrium (HWE) determined by Haploview
software.
Statistical analysis
Linear models with different slopes and intercepts for each
genotype were used to compare the effect of genotype on INK4/
ARF transcripts adjusting for age. ANOVA and Kruskal-Wallis
tests were used to compare the mean gene expression across the
genotypes (Table S2). A Student’s t-test was used to compute p-
values for the pair-wise comparisons between the genotypes, and
p-values were adjusted using Bonferroni method for multiple
comparisons (Table S2). All analysis was performed using SAS (v.
9.1.3, SAS Institute Inc).
Results
We selected six SNPs for genotyping based on strength of
association in previous studies: two associated with atherosclerosis
(rs10757278 and rs518394) [1,2,3,4], two with T2DM (rs10811661
and rs564398) [8,9,10], one with frailty (rs2811712) [16], and one
with melanoma (rs11515, in the 39 UTR of p16
INK4a and ARF)[17]
(Fig. 1). These SNPs were also chosen to have limited LD across the
locus (Fig. 1 and Table S1). While no significant associations were
noted between expression of any 9p21 transcript and five of the six
SNPs analyzed (not shown), a strong association was noted between
INK4/ARF transcript expression (log2-transformed or DDCT)a n d
rs10757278 genotype (Fig. 2 and Table S2). This SNP and nearby
SNPs in high LD have been reproducibly associated with
atherosclerotic disease in independent studies [1,2,3,4,6,7].
We observed significantly reduced expression of ARF, p15
INK4b,
p16
INK4a, and ANRIL in GG vs. AA individuals (Fig. 2A and 2B).
The increase in expression in AA vs. GG donors was 2.1 to 2.8-
fold for all four INK4/ARF transcripts, with an intermediate effect
seen in AG individuals for each transcript. These effects were
highly significant after adjustment for multiple comparisons
(p,0.0001, Table S2). While expression of p16
INK4a is highly
dynamic in PBTL with age, differences between genotypes were
significant at all ages (Fig. 2B). Moreover, the p16
INK4a and ARF
have two shared exons (Fig. 1, reviewed in [12]), and aggregate
p16
INK4a/ARF expression detected with primers/probe pairs that
span the shared exons (Exon2/3) were also significantly increased
in AA individuals compared to GG individuals (Fig. 2A). In
contrast, expression of a more distant 9p21 transcript, MTAP,a s
Figure 1. The human INK4/ARF locus and CAD associated SNPs. (I) INK4/ARF-associated transcripts and tested SNPs are shown as well as the
location of MTAP, another gene at 9p21. Blue colored boxes indicate exons 2 and 3 shared by p16
INK4a and ARF. The location of 9p21 SNPs (II) and
linkage disequilibrium (LD) coefficient values (III) from HapMap[42] CEU (Utah residents with ancestry from northern and western Europe) are shown.
The LD plot of D9/LOD was generated using Haploview software [42]. The strength of LD increases from white to blue to red: white (disequilibrium
coefficient (D9) ,1 and LOD score ,2); blue (D9=1 and LOD score ,2); pink (D9,1 and LOD score $2); and bright red (D9=1 and LOD score $2).
(IV) The correlations with CAD and other age-associated conditions of the indicated SNPs are indicated by corresponding colors.
doi:10.1371/journal.pone.0005027.g001
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CIP and IRF8) was
not associated with rs10757278 genotype (Fig. 2A). As the G-allele
correlates with increased risk of atherosclerotic disease [6,18],
these data indicate that decreased expression of all members of the
INK4/ARF locus in PBTL is associated with a higher risk of
atherosclerotic disease.
Discussion
Here, we show that the expression of INK4/ARF locus
transcripts is significantly reduced in individuals harboring a
common allele of a 9p21 SNP ,120 kb from the INK4a/ARF
locus. This observation suggests a surprising human heterogeneity
in the expression of genes that have been associated with various
aspects of mammalian cancer and aging (reviewed in [19]),
including a particular importance in lymphocyte aging [20]. We
believe this observation can be most parsimoniously explained by
the existence of a polymorphic cis-regulatory element that
influences expression of the INK4/ARF locus and that is closely
linked to rs10757278. Cis-regulatory element located more than
100 kb apart from affected open reading frames (ORFs) are well-
described at other loci [21].
It is important to note that rs10757278 and linked SNPs in high
LD (e.g. rs1333049) are associated with family history of
atheroscleroticdisease,but notothertraditionalriskfactorsincluding
body mass index, diabetes, tobacco use, blood pressure, C-reactive
Figure 2. Reduced transcription of the INK4/ARF locus is associated with the atherosclerosis risk allele of rs10757278. (A) The risk
allele (G) of rs10757278 is associated with reduced transcription of all four INK4/ARF-associated transcripts. Adjusted p-values (t-test) comparing mean
AA vs. GG expression are shown: *p,0.001; **p,0.0005; ***p,0.0001. See also Table S2 for details of ANOVA and Kruskal-Wallis comparisons. Error
bars indicate SEM. (B) Expression of genes within INK4/ARF locus is associated with the risk allele of rs10757278 throughout chronological age.
*p,0.01 for overall slope comparison; intercepts are not compared due to significant difference in slopes. **p.0.05 for overall slope comparison and
p,0.0001 for overall intercept comparison.
doi:10.1371/journal.pone.0005027.g002
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strongly associated with coronary artery calcification, premature
atherosclerosis and angiographically characterized disease [2,24,25].
Therefore, we believe the present finding supports a direct link
between INK4/ARF expression and atherogenesis.
We believe a reasonable argument can be made for how each of
the INK4/ARF transcripts might modulate the earliest stages of
atherosclerosis. The INK4-class cyclin dependent kinase (CDK)
inhibitors, of which p15
INK4b and p16
INK4a are founding
members, block cell cycle progression by inhibiting the activity
of the proliferative kinases CDK4 and CDK6. A role for cell cycle
inhibitors has been postulated in promoting favorable vascular
remodeling and preventing pathologic intimal hyperplasia by
regulating G1 to S phase progression in vascular smooth muscle
cells (reviewed in [26]). In support of this notion, mice lacking
p16
INK4a have been shown to be more sensitive to vascular intimal
hyperplasia in a carotid artery injury model [27], suggesting that
p16
INK4a protects against atherogenesis by limiting a pathologic
vascular reaction to injury in some circumstances. Likewise, TGF-
b signaling is thought to attenuate atherogenesis [28,29], and the
anti-proliferative effects of TGF-b signaling are in part mediated
by p15
INK4b (ref. [30]). ARF, on the other hand, inhibits the cell
cycle by activating the p53 tumor suppressor. In murine systems,
Arf expression and has been shown to exert a general anti-aging
effect [31,32], presumably through an enhancement of DNA
repair. Likewise, Arf expression has been shown to play a specific
role in vascular biology in the development of the murine eye [33].
Together, expression of p15
INK4b, p16
INK4a or ARF, either alone
or in combination could plausibly retard atherogenesis, most likely
by limiting pathogenic vascular proliferation.
As the putative non-coding RNA ANRIL spans the risk-
associated SNPs, ANRIL might be directly affected by the
unknown causative genetic variant in strong LD with
rs10757278. Importantly, Polycomb group (PcG) complexes
potently repress INK4/ARF locus expression [34,35,36], and cis-
acting non-coding RNAs have been shown to play an important
role in PcG-mediated repression at other loci (e.g. Xist at the
inactive X-chromosome, reviewed in [37,38]). Therefore, it is
possible that altered ANRIL expression could potentially regulate
INK4/ARF repression through PcG complexes, explaining why all
four INK4/ARF transcripts are coordinately associated with
rs10757278 genotype. On the other hand, ANRIL could also
influence the expression of other genes in trans- as has been
recently reported for HOTAIR at Hox loci [39].
Importantly, however, it is likely the effects of INK4/ARF
expression on the development of atherosclerosis do not result
from their expression in PBTL, but rather, observations in PBTL
may serve as a surrogate for INK4/ARF expression in other tissues.
As cis-regulatory elements may act as enhancers in one tissue and
repressors in another, it is also possible that genetic variants in LD
with rs10757278 genotype might be associated with increased
INK4/ARF transcript expression in other tissues of greater
relevance to atherogenesis (e.g. endothelial progenitors or vascular
smooth muscle cells). Several investigators have argued that
cellular senescence, which is induced by p16
INK4a, promotes
atherosclerosis (e.g. [40,41]), and we do not believe the present
results are necessarily inconsistent with that view. Carefully
designed murine studies will serve to elucidate the effects of
INK4/ARF expression on atherogenesis.
In summary, our data suggests that a common genetic variant in
strong LD with rs10757278 at chromosome 9p21 influences the
expression of the INK4/ARF-associated transcripts, but not MTAP,
in PBTL. These observations provocatively suggest a crucial role




Found at: doi:10.1371/journal.pone.0005027.s001 (2.37 MB TIF)
Table S2
Found at: doi:10.1371/journal.pone.0005027.s002 (2.42 MB TIF)
Acknowledgments
The authors would like to thank C. Patterson, J. Cohen, and T.
Rosenzweig for critical reading of the manuscript; P. Dillon for assistance
with subject accrual; and K. Janakiraman for technical advice.
Author Contributions
Conceived and designed the experiments: YL HS NS. Performed the
experiments: YL CT. Analyzed the data: YL HS HC CT JGI NT NS.
Contributed reagents/materials/analysis tools: YL HS CB. Wrote the
paper: YL HS HC KM JGI NT NS.
References
1. Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, et al.
(2007) A common variant on chromosome 9p21 affects the risk of myocardial
infarction. Science 316: 1491–1493.
2. McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, et al. (2007) A
common allele on chromosome 9 associated with coronary heart disease. Science
316: 1488–1491.
3. The Wellcome Trust Case Control Consortium (2007) Genome-wide association
study of 14,000 cases of seven common diseases and 3,000 shared controls.
Nature 447: 661–678.
4. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, et al. (2007)
Genomewide association analysis of coronary artery disease. N Engl J Med 357:
443–453.
5. Broadbent HM, Peden JF, Lorkowski S, Goel A, Ongen H, et al. (2008)
Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly
linkedSNPsintheANRILlocusonchromosome9p.HumMolGenet17:806–814.
6. Helgadottir A, Thorleifsson G, Magnusson KP, Gretarsdottir S,
Steinthorsdottir V, et al. (2008) The same sequence variant on 9p21 associates
with myocardial infarction, abdominal aortic aneurysm and intracranial
aneurysm. Nat Genet 40: 217–224.
7. Matarin M, Brown WM, Singleton A, Hardy JA, Meschia JF (2008) Whole
genome analyses suggest ischemic stroke and heart disease share an association
with polymorphisms on chromosome 9p21. Stroke 39: 1586–1589.
8. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, et al. (2007) A genome-
wide association study of type 2 diabetes in Finns detects multiple susceptibility
variants. Science 316: 1341–1345.
9. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, et al. (2007)
Genome-wide association analysis identifies loci for type 2 diabetes and
triglyceride levels. Science 316: 1331–1336.
10. Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, et al. (2007)
Replication of genome-wide association signals in UK samples reveals risk loci
for type 2 diabetes. Science 316: 1336–1341.
11. Krishnamurthy J, Ramsey MR, Ligon KL, Torrice C, Koh A, et al. (2006)
p16INK4a induces an age-dependent decline in islet regenerative potential.
Nature 443: 453–457.
12. Kim WY, Sharpless NE (2006) The regulation of INK4/ARF in cancer and
aging. Cell 127: 265–275.
13. Pasmant E, Laurendeau I, Heron D, Vidaud M, Vidaud D, et al. (2007)
Characterization of a germ-line deletion, including the entire INK4/ARF locus,
in a melanoma-neural system tumor family: identification of ANRIL, an
antisense noncoding RNA whose expression coclusters with ARF. Cancer Res
67: 3963–3969.
14. Shields JM, Thomas NE, Cregger M, Berger AJ, Leslie M, et al. (2007) Lack of
extracellular signal-regulated kinase mitogen-activated protein kinase signaling
shows a new type of melanoma. Cancer Res 67: 1502–1512.
15. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using
real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:
402–408.
16. Melzer D, Frayling TM, Murray A, Hurst AJ, Harries LW, et al. (2007) A
common variant of the p16(INK4a) genetic region is associated with physical
function in older people. Mech Ageing Dev 128: 370–377.
INK4/ARF and Atherosclerosis
PLoS ONE | www.plosone.org 4 April 2009 | Volume 4 | Issue 4 | e502717. Kumar R, Smeds J, Berggren P, Straume O, Rozell BL, et al. (2001) A single
nucleotide polymorphism in the 39untranslated region of the CDKN2A gene is
common in sporadic primary melanomas but mutations in the CDKN2B,
CDKN2C, CDK4 and p53 genes are rare. Int J Cancer 95: 388–393.
18. Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, et al.
(2007) A common variant on chromosome 9p21 affects the risk of myocardial
infarction. Science 316: 1491–1493.
19. Sharpless NE, DePinho RA (2007) How stem cells age and why this makes us
grow old. Nat Rev Mol Cell Biol 8: 703–713.
20. Signer RA, Montecino-Rodriguez E, Witte ON, Dorshkind K (2008) Aging and
cancer resistance in lymphoid progenitors are linked processes conferred by
p16Ink4a and Arf. Genes Dev 22: 3115–3120.
21. Kleinjan DA, van Heyningen V (2005) Long-range control of gene expression:
emerging mechanisms and disruption in disease. Am J Hum Genet 76: 8–32.
22. Schunkert H, Gotz A, Braund P, McGinnis R, Tregouet DA, et al. (2008)
Repeated replication and a prospective meta-analysis of the association between
chromosome 9p21.3 and coronary artery disease. Circulation 117: 1675–1684.
23. Paynter NP, Chasman DI, Buring JE, Shiffman D, Cook NR, et al. (2009)
Cardiovascular Disease Risk Prediction With and Without Knowledge of
Genetic Variation at Chromosome 9p21.3. Ann Intern Med 150: 65–72.
24. Anderson JL, Horne BD, Kolek MJ, Muhlestein JB, Mower CP, et al. (2008)
Genetic variation at the 9p21 locus predicts angiographic coronary artery
disease prevalence but not extent and has clinical utility. Am Heart J 156:
1155–1162 e1152.
25. Muendlein A, Saely CH, Rhomberg S, Sonderegger G, Loacker S, et al. (2008)
Evaluation of the association of genetic variants on the chromosomal loci
9p21.3, 6q25.1, and 2q36.3 with angiographically characterized coronary artery
disease. Atherosclerosis; In Press.
26. Boehm M, Nabel EG (2003) The cell cycle and cardiovascular diseases. Prog
Cell Cycle Res 5: 19–30.
27. Gizard F, Amant C, Barbier O, Bellosta S, Robillard R, et al. (2005) PPAR
alpha inhibits vascular smooth muscle cell proliferation underlying intimal
hyperplasia by inducing the tumor suppressor p16INK4a. J Clin Invest 115:
3228–3238.
28. Kalinina N, Agrotis A, Antropova Y, Ilyinskaya O, Smirnov V, et al. (2004)
Smad Expression in Human Atherosclerotic Lesions: Evidence for Impaired
TGF-{beta}/Smad Signaling in Smooth Muscle Cells of Fibrofatty Lesions.
Arterioscler Thromb Vasc Biol 24: 1391–1396.
29. Grainger DJ (2004) Transforming growth factor {beta} and atherosclerosis: so
far, so good for the protective cytokine hypothesis. Arterioscler Thromb Vasc
Biol 24: 399–404.
30. Reynisdottir I, Polyak K, Iavarone A, Massague J (1995) Kip/Cip and Ink4 Cdk
inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes
Dev 9: 1831–1845.
31. Matheu A, Maraver A, Klatt P, Flores I, Garcia-Cao I, et al. (2007) Delayed
ageing through damage protection by the Arf/p53 pathway. Nature 448:
375–379.
32. Baker DJ, Perez-Terzic C, Jin F, Pitel K, Niederlander NJ, et al. (2008)
Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by
BubR1 insufficiency. Nat Cell Biol 10: 825–836.
33. McKeller RN, Fowler JL, Cunningham JJ, Warner N, Smeyne RJ, et al. (2002)
The Arf tumor suppressor gene promotes hyaloid vascular regression during
mouse eye development. Proceedings of the National Academy of Sciences of the
United States of America 99: 3848–3853.
34. Kotake Y, Cao R, Viatour P, Sage J, Zhang Y, et al. (2007) pRB family proteins
are required for H3K27 trimethylation and Polycomb repression complexes
binding to and silencing p16INK4alpha tumor suppressor gene. Genes Dev 21:
49–54.
35. Bracken AP, Kleine-Kohlbrecher D, Dietrich N, Pasini D, Gargiulo G, et al.
(2007) The Polycomb group proteins bind throughout the INK4A-ARF locus
and are disassociated in senescent cells. Genes Dev 21: 525–530.
36. He J, Kallin EM, Tsukada Y-i, Zhang Y (2008) The H3K36 demethylase
Jhdm1b/Kdm2b regulates cell proliferation and senescence through p15Ink4b.
Nat Struct Mol Biol 15: 1169–1175.
37. Ng K, Pullirsch D, Leeb M, Wutz A (2007) Xist and the order of silencing.
EMBO Rep 8: 34–39.
38. Wutz A (2007) Xist function: bridging chromatin and stem cells. Trends Genet
23: 457–464.
39. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, et al. (2007) Functional
Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by
Noncoding RNAs. Cell 129: 1311–1323.
40. Matthews C, Gorenne I, Scott S, Figg N, Kirkpatrick P, et al. (2006) Vascular
smooth muscle cells undergo telomere-based senescence in human atheroscle-
rosis: effects of telomerase and oxidative stress. Circ Res 99: 156–164.
41. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, Wang T, Gregg D, et al.
(2003) Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 108:
457–463.
42. The International HapMap C (2005) A haplotype map of the human genome.
Nature 437: 1299–1320.
INK4/ARF and Atherosclerosis
PLoS ONE | www.plosone.org 5 April 2009 | Volume 4 | Issue 4 | e5027